-
公开(公告)号：US20220242952A1
公开(公告)日：2022-08-04
申请号：US17605285
申请日：2020-05-04
Applicant: MORPHOSYS AG
Inventor： Christian KUFFER , Guenter FINGERLE-ROWSON , Mark WINDERLICH , Jan ENDELL
Abstract: The present disclosure provides characteristics and biomarkers in patients that benefit from treatment with anti-CD19 antibodies (MOR00208, XmAb5574). Furthermore, the present application relates to anti-CD19 antibodies for the treatment of leukemia or lymphoma in patients having a peripheral NK cell count at baseline of less or equal to 100 NK cells/μl
Search Results
1
records
(took 0.009 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
